Holen Sie sich die Stockscreener-App
0.7708
2.31%
-0.0182
Schlusskurs vom Vortag:
$0.789
Offen:
$0.8
24-Stunden-Volumen:
52,556
Relative Volume:
0.39
Marktkapitalisierung:
$5.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.28M
KGV:
-0.0554
EPS:
-13.91
Netto-Cashflow:
$-13.75M
1W Leistung:
-2.46%
1M Leistung:
+10.11%
6M Leistung:
-25.17%
1J Leistung:
-80.46%
1-Tages-Spanne:
$0.7635
$0.8001
1-Wochen-Bereich:
$0.7444
$0.807
52-Wochen-Spanne:
$0.65
$7.50
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Firmenname
Pasithea Therapeutics Corp
Sektor
Branche
Telefon
(702) 514-4174
Adresse
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Vergleichen Sie KTTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.7708 | 5.82M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
Pasithea Therapeutics Corp. stock trendline breakdownTrade Risk Assessment & Reliable Price Action Trade Plans - Newser
Analyzing net buyer seller activity in Pasithea Therapeutics Corp.Weekly Risk Summary & Free Daily Entry Point Trade Alerts - Newser
What recovery options are there for Pasithea Therapeutics Corp.Quarterly Profit Report & Stepwise Entry/Exit Trade Alerts - Newser
Published on: 2025-09-13 05:28:12 - Newser
Is Pasithea Therapeutics Corp. stock entering bullish territoryTrend Reversal & Low Risk Entry Point Guides - Newser
What MACD and RSI say about Pasithea Therapeutics Corp.Day Trade & Safe Capital Preservation Plans - Newser
How high can Pasithea Therapeutics Corp. stock goTrade Exit Summary & Safe Capital Growth Tips - Newser
Will Pasithea Therapeutics Corp. rebound enough to break evenBull Run & Low Drawdown Investment Ideas - Newser
Real time alert setup for Pasithea Therapeutics Corp. performanceJuly 2025 Action & AI Enhanced Trading Signals - Newser
How to interpret RSI for Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Gainers & Stepwise Trade Signal Implementation - Newser
Is Pasithea Therapeutics Corp. trending in predictive chart modelsPortfolio Gains Summary & AI Optimized Trading Strategy Guides - Newser
Using Ichimoku Cloud for Pasithea Therapeutics Corp. Equity Warrant technicalsMarket Performance Recap & Weekly Return Optimization Alerts - Newser
Volume spikes in Pasithea Therapeutics Corp. stock – what they mean2025 Top Gainers & Risk Managed Trade Strategies - Newser
Pasithea Therapeutics Corp. stock prediction for this weekGap Up & Reliable Entry Point Trade Alerts - Newser
Signal strength of Pasithea Therapeutics Corp. stock in tech scannersJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
Visual analytics tools that track Pasithea Therapeutics Corp. Equity Warrant performanceRisk Management & Real-Time Chart Breakout Alerts - Newser
Using fundamentals and technicals on Pasithea Therapeutics Corp. Equity WarrantStock Surge & Free Safe Entry Trade Signal Reports - Newser
Pasithea Therapeutics Corp. stock outlook for YEARPortfolio Risk Summary & Real-Time Chart Pattern Alerts - Newser
Will Pasithea Therapeutics Corp. Equity Warrant outperform the market2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Will Pasithea Therapeutics Corp. Equity Warrant stock recover after recent dropWeekly Trend Summary & Long Hold Capital Preservation Tips - Newser
Can volume confirm reversal in Pasithea Therapeutics Corp. Equity Warrant2025 Institutional Moves & Weekly Watchlist for Consistent Profits - Newser
What the charts say about Pasithea Therapeutics Corp. todayFed Meeting & Fast Gain Stock Tips - Newser
is pasithea therapeutics corp. equity warrant stock poised for growth2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser
Will Pasithea Therapeutics Corp. Equity Warrant rebound enough to break evenJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - Newser
Can volume confirm reversal in Pasithea Therapeutics Corp.Recession Risk & Safe Entry Point Identification - Newser
How to escape a deep drawdown in Pasithea Therapeutics Corp.Quarterly Profit Review & Daily Oversold Bounce Ideas - Newser
What Fibonacci levels say about Pasithea Therapeutics Corp. Equity Warrant reboundWeekly Risk Report & AI Powered Buy and Sell Recommendations - Newser
Relative strength of Pasithea Therapeutics Corp. in sector analysisTrade Ideas & High Accuracy Swing Entry Alerts - Newser
Applying Wyckoff theory to Pasithea Therapeutics Corp. Equity Warrant stock2025 AllTime Highs & Technical Confirmation Alerts - Newser
Price momentum metrics for Pasithea Therapeutics Corp. Equity Warrant explained2025 Key Lessons & Step-by-Step Trade Execution Guides - Newser
Will Pasithea Therapeutics Corp. bounce back from current supportWeekly Trade Review & Real-Time Buy Signal Notifications - Newser
Chart overlay techniques for tracking Pasithea Therapeutics Corp. Equity Warrant2025 Top Decliners & Technical Entry and Exit Alerts - Newser
What indicators show strength in Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - Newser
Is Pasithea Therapeutics Corp. Equity Warrant stock poised for growth2025 Analyst Calls & Consistent Profit Trading Strategies - Newser
Will Pasithea Therapeutics Corp. see short term momentumSell Signal & Verified Short-Term Trading Plans - Newser
Market reaction to Pasithea Therapeutics Corp. Equity Warrant’s recent news - Newser
Pasithea Therapeutics Corp. Equity Warrant stock outlook for YEARJuly 2025 Highlights & Consistent Growth Stock Picks - Newser
Using Python tools to backtest Pasithea Therapeutics Corp. Equity Warrant strategiesRate Hike & Weekly Watchlist of Top Performers - Newser
What’s next for Pasithea Therapeutics Corp. stock priceQuarterly Profit Review & Community Consensus Trade Signals - Newser
Pasithea Therapeutics Approves Key Proposals at Annual Meeting - MSN
Pasithea Therapeutics (NASDAQ:KTTA) Stock Price Up 3% – Here’s Why - Defense World
What’s the recovery path for long term holders of Pasithea Therapeutics Corp. Equity WarrantTrade Exit Report & Low Drawdown Trading Strategies - Newser
Is Pasithea Therapeutics Corp. Equity Warrant stock entering bullish territoryTreasury Yields & AI Powered Market Entry Ideas - Newser
Heatmap analysis for Pasithea Therapeutics Corp. Equity Warrant and competitorsStop Loss & High Accuracy Trade Signal Alerts - Newser
Published on: 2025-09-10 01:06:06 - Newser
Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pasithea Therapeutics Corp-Aktie (KTTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):